MYCN and neuroblastoma: In this study, we retrospectively evaluated the clinical (age, sex and tumor stage) and biological (MYCN amplification; levels of lactate dehydrogenase, ferritin, vanillylmandelic and neuron-specific enolase) features of NB, GNBn and GNBi to provide more evidence to inform clinical diagnoses and therapeutic approaches.